Assertio (ASRT) News Today $0.89 +0.04 (+5.09%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Assertio Therapeutics Announces Leadership Changes and Board AdditionDecember 18 at 5:09 AM | markets.businessinsider.comHC Wainwright Reiterates "Buy" Rating for Assertio (NASDAQ:ASRT)December 18 at 1:55 AM | americanbankingnews.comPositive Clinical Results and Market Potential Drive Buy Rating for Assertio TherapeuticsDecember 17, 2024 | markets.businessinsider.comAssertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of DirectorsDecember 17, 2024 | globenewswire.comAssertio's (ASRT) Buy Rating Reiterated at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $4.00 target price on shares of Assertio in a research report on Monday.December 16, 2024 | marketbeat.comAssertio Holdings, Inc. (NASDAQ:ASRT) Short Interest UpdateAssertio Holdings, Inc. (NASDAQ:ASRT - Get Free Report) was the target of a significant decrease in short interest in the month of November. As of November 30th, there was short interest totalling 5,540,000 shares, a decrease of 11.5% from the November 15th total of 6,260,000 shares. Based on an average daily volume of 683,000 shares, the days-to-cover ratio is presently 8.1 days.December 15, 2024 | marketbeat.comAssertio Holdings, Inc.: Assertio Announces Results of Rolvedon (eflapegrastim-xnst) injection Same-Day Dosing Clinical StudyDecember 13, 2024 | finanznachrichten.deAssertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical StudyDecember 13, 2024 | globenewswire.comAssertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCODecember 12, 2024 | markets.businessinsider.comLake Street Sticks to Its Buy Rating for Assertio Therapeutics (ASRT)November 28, 2024 | markets.businessinsider.comHC Wainwright Analysts Boost Earnings Estimates for AssertioAssertio Holdings, Inc. (NASDAQ:ASRT - Free Report) - Equities researchers at HC Wainwright lifted their FY2024 earnings estimates for Assertio in a research report issued to clients and investors on Monday, November 25th. HC Wainwright analyst R. Selvaraju now forecasts that the company will earNovember 28, 2024 | marketbeat.comAssertio Therapeutics: Strong Buy Rating Backed by Robust Margins and Strategic Revenue GrowthNovember 26, 2024 | markets.businessinsider.comInsider Buying: Assertio Holdings, Inc. (NASDAQ:ASRT) Director Acquires 75,000 Shares of StockNovember 20, 2024 | insidertrades.comHeather L. Mason Acquires 75,000 Shares of Assertio Holdings, Inc. (NASDAQ:ASRT) StockAssertio Holdings, Inc. (NASDAQ:ASRT - Get Free Report) Director Heather L. Mason acquired 75,000 shares of the business's stock in a transaction that occurred on Monday, November 18th. The stock was bought at an average cost of $0.80 per share, for a total transaction of $60,000.00. Following the completion of the purchase, the director now owns 287,650 shares of the company's stock, valued at $230,120. This trade represents a 35.27 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.November 19, 2024 | marketbeat.comBuxton Helmsley Calls for Senate Hearing on Well-Documented Evident Clinical Data Fraud at AssertioNovember 15, 2024 | tmcnet.comAssertio Therapeutics (ASRT) Receives a Buy from Lake StreetNovember 13, 2024 | markets.businessinsider.comAssertio Holdings price target lowered to $2.15 from $2.75 at Alliance GlobalNovember 13, 2024 | markets.businessinsider.comAssertio calls short-seller claims about accounting practices ‘false, baseless’November 12, 2024 | markets.businessinsider.comAssertio stock gains amid Q3 earnings, clash with activist investorNovember 12, 2024 | msn.comAssertio Holdings, Inc. (NASDAQ:ASRT) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | msn.comAssertio Holdings, Inc. (ASRT) Q3 2024 Earnings Call TranscriptNovember 11, 2024 | seekingalpha.comAssertio Reports Third Quarter 2024 Financial ResultsNovember 11, 2024 | globenewswire.comBuxton Helmsley Releases Evidence of Product-Related Fraud at AssertioNovember 11, 2024 | businesswire.comAssertio Provides Response to Letter from Short-sellerNovember 11, 2024 | globenewswire.comA Look at Assertio Holdings's Upcoming Earnings ReportNovember 8, 2024 | benzinga.comAssertio Holdings Inc (ASRT) Q3 2024: Everything You Need to Know Ahead of EarningsNovember 8, 2024 | finance.yahoo.comBuxton Helmsley Issues Letter to Assertio Stockholders Disclosing Inversion to Short Position Following Board Refusal to Address Product-Related FraudNovember 8, 2024 | businesswire.comSidoti Csr Weighs in on Assertio's Q3 Earnings (NASDAQ:ASRT)Assertio Holdings, Inc. (NASDAQ:ASRT - Free Report) - Equities researchers at Sidoti Csr cut their Q3 2024 earnings per share (EPS) estimates for shares of Assertio in a report released on Wednesday, November 6th. Sidoti Csr analyst J. Sidoti now anticipates that the company will post earnings ofNovember 8, 2024 | marketbeat.comAssertio (ASRT) Set to Announce Quarterly Earnings on MondayAssertio (NASDAQ:ASRT) will be releasing earnings after the market closes on Monday, November 11, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=440141)November 4, 2024 | marketbeat.comAssertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024October 11, 2024 | globenewswire.comAssertio Holdings Inc (ASRT) Q2 2024 Earnings Call Highlights: Navigating Sales Challenges and ...October 10, 2024 | finance.yahoo.comAssertio Holdings, Inc. (NASDAQ:ASRT) Shares Sold by AQR Capital Management LLCAQR Capital Management LLC reduced its stake in shares of Assertio Holdings, Inc. (NASDAQ:ASRT - Free Report) by 28.6% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,307,849 shares of the company's stock after selling 922,75October 8, 2024 | marketbeat.comAssertio Holdings (NASDAQ:ASRT) Stock Quotes, Forecast and News SummaryOctober 7, 2024 | benzinga.comAssertio Holdings (NASDAQ:ASRT) Stock, Guidance And ForecastOctober 7, 2024 | benzinga.comAssertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)October 4, 2024 | globenewswire.comAssertio Holdings: Management Change Could Improve Comeback ChancesSeptember 12, 2024 | seekingalpha.comAssertio Holdings, Inc. Expected to Earn Q1 2025 Earnings of $0.00 Per Share (NASDAQ:ASRT)Assertio Holdings, Inc. (NASDAQ:ASRT - Free Report) - Equities researchers at Sidoti Csr reduced their Q1 2025 earnings per share estimates for Assertio in a note issued to investors on Thursday, September 5th. Sidoti Csr analyst J. Sidoti now expects that the company will earn $0.00 per share foSeptember 6, 2024 | marketbeat.comAssertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024September 3, 2024 | globenewswire.comAssertio Therapeutics: Strong Buy Rating on Robust Portfolio and Strategic GrowthAugust 21, 2024 | markets.businessinsider.comAssertio Holdings, Inc. (NASDAQ:ASRT) Receives Average Recommendation of "Buy" from AnalystsShares of Assertio Holdings, Inc. (NASDAQ:ASRT - Get Free Report) have been given a consensus rating of "Buy" by the four analysts that are presently covering the company, MarketBeat reports. Four research analysts have rated the stock with a buy rating. The average 1 year price target among brokeAugust 20, 2024 | marketbeat.comShort Interest in Assertio Holdings, Inc. (NASDAQ:ASRT) Drops By 7.3%Assertio Holdings, Inc. (NASDAQ:ASRT - Get Free Report) saw a significant decline in short interest in July. As of July 31st, there was short interest totalling 6,190,000 shares, a decline of 7.3% from the July 15th total of 6,680,000 shares. Based on an average daily volume of 1,140,000 shares, the short-interest ratio is presently 5.4 days.August 19, 2024 | marketbeat.comAssertio (NASDAQ:ASRT) Announces Earnings Results, Misses Estimates By $0.02 EPSAssertio (NASDAQ:ASRT - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.04) earnings per share for the quarter, missing analysts' consensus estimates of ($0.02) by ($0.02). The company had revenue of $31.13 million during the quarter, compared to analyst estimates of $30.37 million. Assertio had a positive return on equity of 10.80% and a negative net margin of 234.40%. During the same period last year, the firm earned $0.13 earnings per share.August 11, 2024 | marketbeat.comAssertio Holdings, Inc. (NASDAQ:ASRT) Q2 2024 Earnings Call TranscriptAugust 10, 2024 | insidermonkey.comBuy Rating Affirmed for Assertio Therapeutics on Strong Financials and Market PositionAugust 9, 2024 | markets.businessinsider.comAssertio Reports Second Quarter 2024 Financial ResultsAugust 7, 2024 | globenewswire.comAssertio Holdings Inc ASRTAugust 2, 2024 | morningstar.comAssertio (ASRT) Scheduled to Post Quarterly Earnings on WednesdayAssertio (NASDAQ:ASRT) will be releasing earnings after the market closes on Wednesday, August 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=440141)July 31, 2024 | marketbeat.comMaxim Group Initiates Coverage of Assertio Holdings (ASRT) with Buy RecommendationJuly 27, 2024 | msn.comRussell Investments Group Ltd. Has $2.25 Million Stock Position in Assertio Holdings, Inc. (NASDAQ:ASRT)Russell Investments Group Ltd. boosted its holdings in shares of Assertio Holdings, Inc. (NASDAQ:ASRT - Free Report) by 22,096.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,347,024 shares of the company's stock afterJuly 27, 2024 | marketbeat.comAssertio Holdings, Inc. (NASDAQ:ASRT) Given Consensus Recommendation of "Buy" by BrokeragesShares of Assertio Holdings, Inc. (NASDAQ:ASRT - Get Free Report) have received a consensus rating of "Buy" from the four ratings firms that are covering the firm, MarketBeat reports. Four equities research analysts have rated the stock with a buy recommendation. The average 1-year price target amJuly 26, 2024 | marketbeat.com Get Assertio News Delivered to You Automatically Sign up to receive the latest news and ratings for ASRT and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now ASRT Media Mentions By Week ASRT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ASRT News Sentiment▼0.360.60▲Average Medical News Sentiment ASRT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ASRT Articles This Week▼73▲ASRT Articles Average Week Get Assertio News Delivered to You Automatically Sign up to receive the latest news and ratings for ASRT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies biote News Today Design Therapeutics News Today Voyager Therapeutics News Today Contineum Therapeutics News Today Acelyrin News Today Kamada News Today Canopy Growth News Today Trevi Therapeutics News Today Aquestive Therapeutics News Today Eton Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ASRT) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Assertio Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Assertio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.